Melitrix Inc. Information

"Where innovation becomes accessible medicine". Melitrix is a specialty pharmaceutical company building its own portfolio of specialty pharmaceuticals, generics, and consumer health products and helping other companies develop, manufacture, and launch across new markets, backed by an established European and Indian manufacturing and regulatory network. Our platform spans five integrated capabilities: specialty pharmaceuticals on the 505(b)(2) pathway (led by MT-01, currently in stability studies), a generics pipeline of sterile injectables, oral liquids, and oral solids progressing toward ANDA filings, a consumer health range of 20 color cosmetic and 10 nutraceutical formulations, development and regulatory consulting for partner companies, and CDMO and manufacturing access across a vetted EU-GMP and WHO-GMP network. Founded in 2026 and privately held, Melitrix is built for the long horizon, choosing programs and partners on merit, not funding cycles.